Wellington Management Group LLP Bluebird Bio, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.91 - $1.75 $600,941 - $1.16 Million	660,375 New	660,375 $845,000
Q4 2023 Feb 12, 2024	BUY	$1.32 - $4.83 $810,006 - $2.96 Million	613,641 New	613,641 $846,000
Q3 2023 Nov 14, 2023	BUY	$3.02 - $4.05 $80,250 - $107,620	26,573 Added 4.78%	582,168 $1.77 Million
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $907,402 - $1.64 Million	325,234 Added 141.18%	555,595 $1.83 Million
Q1 2023 May 12, 2023	SELL	$3.14 - $8.22 $20,419 - $53,454	-6,503 Reduced 2.75%	230,361 $732,000
Q4 2022 Feb 13, 2023	SELL	$5.77 - $8.49 $41,526 - $61,102	-7,197 Reduced 2.95%	236,864 $1.64 Million
Q3 2022 Nov 14, 2022	SELL	$3.75 - $7.39 $22.1 Million - $43.6 Million	-5,895,939 Reduced 96.03%	244,061 $1.54 Million
Q4 2021 Feb 11, 2022	SELL	$8.96 - $16.31 $6.98 Million - $12.7 Million	-778,987 Reduced 11.26%	6,140,000 $61.3 Million
Q3 2021 Nov 15, 2021	SELL	$11.24 - $21.0 $36,496 - $68,187	-3,247 Reduced 0.05%	6,918,987 $132 Million
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $91,841 - $112,460	5,091 Added 0.07%	6,922,234 $221 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $26 Million - $53.1 Million	1,567,978 Added 29.31%	6,917,143 $209 Million
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $51.2 Million - $70.6 Million	-1,863,062 Reduced 25.83%	5,349,165 $231 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $955,882 - $1.21 Million	-27,755 Reduced 0.38%	7,212,227 $389 Million
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $11.4 Million - $19.3 Million	419,668 Added 6.15%	7,239,982 $442 Million
Q1 2020 May 14, 2020	SELL	$26.16 - $63.5 $17.2 Million - $41.8 Million	-657,799 Reduced 8.8%	6,820,314 $313 Million
Q4 2019 Feb 11, 2020	BUY	$46.96 - $61.67 $351 Million - $461 Million	7,478,113 New	7,478,113 $656 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.67 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.64 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.63 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.34 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account